
Evoq Remedies Ltd
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- ₹15.7
- Today's High:
- ₹15.75
- Open Price:
- ₹15.75
- 52W Low:
- ₹10.91
- 52W High:
- ₹24.49
- Prev. Close:
- ₹15.68
- Volume:
- 16000
Company Statistics
- Market Cap.:
- ₹0
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Evoq Remedies Ltd had its IPO on under the ticker symbol EVOQ.
The company operates in the Healthcare sector and Pharmaceuticals industry. Evoq Remedies Ltd has a staff strength of 0 employees.
Stock update
Shares of Evoq Remedies Ltd opened at ₹15.75 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹15.7 - ₹15.75, and closed at ₹15.7.
This is a +0.13% increase from the previous day's closing price.
A total volume of 16,000 shares were traded at the close of the day’s session.
In the last one week, shares of Evoq Remedies Ltd have increased by +4.39%.
Evoq Remedies Ltd's Key Ratios
Evoq Remedies Ltd has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Evoq Remedies Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Evoq Remedies Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Evoq Remedies Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q3.6666666666667, Evoq Remedies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Evoq Remedies Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Evoq Remedies Ltd’s profitability.
Evoq Remedies Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Evoq Remedies Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹0
- Total Liabilities
- ₹0
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Evoq Remedies Ltd ended 1970 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.
Evoq Remedies Ltd ended 1970 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Evoq Remedies Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 1970, Evoq Remedies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Evoq Remedies Ltd paid ₹0 in dividends in 1970.
Other key metrics
- Current Trading Price
- ₹15.7
- 52-Week High
- ₹24.49
- 52-Week Low
- ₹10.91
- Analyst Target Price
- ₹
Evoq Remedies Ltd stock is currently trading at ₹15.7 per share. It touched a 52-week high of ₹24.49 and a 52-week low of ₹24.49. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹14.82 and 200-day moving average was ₹14.8 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.